Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEK162 and Capecitabine in Advanced Biliary Tract Cancer
NCT02773459Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib in biliary tract cancer (BTC), sponsored by Seoul National University Hospital. Started Apr 2016; status: completed.
02
Drugs
binimetinib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT02773459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773459.